Trials / Conditions / Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
4 registered clinical trials studyying Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Hypoxic Red Blood Cells in Sickle Cell Anemia NCT06743113 | Hemanext | N/A |
| Not Yet Recruiting | Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin NCT07175051 | University of Illinois at Chicago | Phase 2 |
| Recruiting | Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies NCT06647979 | Daniel Bauer | Phase 1 |
| Completed | Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia NCT01960413 | Vanderbilt University Medical Center | Phase 2 |